3ADAM B L,VLAHOU A , SEMMES 0 J , et al. Pro-teomic approaches to biomarker discovery in prostate andbladder cancers [ J ] . Proteomics,2001, 1 ( 10 ) ; 1264 -1270.
4GUNAWARDANAC G, DIAMANDISE P. High throughputproteomic strategies for identifying tumour - associated anti-gens[ J]. Cancer Letters, 2007, 249( 1) :110-119.
5SRINIVASP R, SRIVASTAVA S,HAN ASH S, et al. Pro-teomics in early detection of cancer[ J] . Clinical Chemistry,2001, 47(10) :1901-1911.
7YAN J X,DEVENISH A T,WAIT R , et al. Fluores-cence two dimensional difference gel electrophoresis andmass spectrometry based proteomic analysis of Escherichiacoli[ J]. Proteomics, 2002, 2( 12) : 1682-1698.
8GIRIBALDI G, BARBERO G, MANDIU G,et al. Pro-teomic identification of Reticulocalbin 1 as potential tumormarker in renal cell carcinoma [ J ]. Journal of Proteomics,2013, 91:385-392.
9MAURERK, ESCHRICH K,SCHELLENBERGERW, etal. Oral brush biopsy analysis by MALDI-ToF Mass Spec-trometry for early cancer diagnosis [ J ] ? Oral Oncology,2013,49(2) :152-156.
10RODRIGO MAM, ZITKA 0, KRIZKOVA S, et al.MALDI-TOF MS as evolving cancer diagnostic tool : A re-view[ J]. Journal of Pharmaceutical and Biomedical Analy-sis, 2014,46(3) : 245-255.
